Summary of Key Information:

  • Reporting Period: Quarter ended June 30, 2026 (Q1 FY26-27)
  • Nature of Filing / Announcement: Outcome of Board Meeting - Approval of Unaudited Financial Results

Audit Opinion:

Qualified with modified opinion. The limited review report by M/s MGB & Co. LLP has a qualified conclusion due to uncertainty regarding the impairment assessment of intercorporate deposits (ICDs) with Veena Investments Private Limited.

Auditor’s Comment:

  • The auditor is unable to determine whether any adjustment is required to the carrying amount of ICDs outstanding Rs 17,340.27 lakhs as at June 30, 2026, due to the arbitration matter.
  • There is a material uncertainty relating to going concern because the company has negative net worth, and its ability to continue is dependent on improved profitability and cash flows.

Key Financial Highlights [Rs. in lakhs]:

Standalone Results:

  • Revenue from Operations:
  • Quarter ended June 30, 2026: 17,183 (Unaudited)
  • Quarter ended March 31, 2026: 16,249 (Audited, refer note 9)
  • Quarter ended June 30, 2025: 7,867 (Unaudited)
  • Total Income:
  • Quarter ended June 30, 2026: 17,735
  • Quarter ended March 31, 2026: 19,554
  • Quarter ended June 30, 2025: 8,080
  • EBITDA: Not Specified
  • Net Profit:
  • Quarter ended June 30, 2026: 39.99 profit
  • Quarter ended March 31, 2026: (602.37) loss
  • Quarter ended June 30, 2025: (188.60) loss
  • EPS (not annualized, Basic and Diluted):
  • Quarter ended June 30, 2026: 0.03
  • Quarter ended March 31, 2026: (0.51)
  • Quarter ended June 30, 2025: (0.16)
  • Other Equity: Not Specified numerically, but note 5 indicates negative net worth.
  • Cash and Cash Equivalents: Not Specified
  • Debt: Not Specified directly; finance costs are:
  • Quarter ended June 30, 2026: 3.87
  • Quarter ended March 31, 2026: 3.96
  • Quarter ended June 30, 2025: 3.99

Consolidated Results:

Not Specified

Segment-wise Performance:

  • The company has only one identifiable business segment: digital media business.
  • No segment-wise revenue or profit breakdown provided.

Corporate Actions:

  • No dividend declared.
  • The Board approved a Scheme of Reduction and cancellation of NCRPS Capital for Rs 17,340.27 lakhs to be adjusted against ICDs with Veena Investments, and the remaining Rs 26,286.29 lakhs to be reduced. Filed with BSE and NSE on October 7, 2025, and October 8, 2025, respectively, pending approval.

Other Significant Information:

  • Going Concern: The company has negative net worth and current liabilities exceed current assets. Management is focusing on strengthening revenue streams, implementing cost rationalization measures, and projects positive cash flows based on Board-approved business plan.
  • Arbitration with Veena Investments Private Limited (VIPL):
  • ICDs outstanding: Rs 17,340.27 lakhs as of June 30, 2026 (including accrued interest up to December 31, 2024 of Rs 1,385.27 lakhs).
  • VIPL holds 6% Non-cumulative Non-convertible Redeemable Preference Shares (NCRPS) of Rs 43,626.56 lakhs redeemable on November 1, 2036.
  • Arbitration Award dated August 20, 2025, directed setoff of ICDs against NCRPS redemption at Rs 17,340.27 lakhs.
  • Scheme of Reduction approved by Board on September 18, 2025.
  • Interest not accrued from January 1, 2025; no impairment adjustment made.
  • Deferred Tax Assets: Reversed Rs 645.28 lakhs in quarter ended March 31, 2026, and Rs 631.44 lakhs for year ended March 31, 2026, due to uncertainty about future taxable income.
  • Other Expenses include:
  • Production and content expenses: Q1 Jun26: 23.99, Q4 Mar26: 26.24, Q1 Jun25: 27.28
  • Marketing, distribution, and business promotion expenses: Q1 Jun26: 0.98, Q4 Mar26: 1.45, Q1 Jun25: 5.92
  • Rates and taxes: Q1 Jun26: 5.54, Q4 Mar26: 5.20, Q1 Jun25: 5.64
  • Provision for doubtful debts and advances: Q1 Jun26: 0.02, Q4 Mar26: 0.02, Q1 Jun25: 9.11